Trial Details
COMPLETEDBasic Information
| Clinical ID | c403 |
|---|---|
| Identifier | NCT03056924 |
| Trial Title | Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | BIOLOGICAL: Pneumococcal Pneumonia vaccine|BIOLOGICAL: Influenza vaccine|BIOLOGICAL: Hepatitis B vaccine |
Participant Information
| Sponsor | Boston Medical Center |
|---|---|
| City | Boston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2017-07-05 |
|---|---|
| Primary Completion Date | 2019-01-15 |
| Completion Date | 2019-01-15 |